Literature DB >> 14680398

Comparison of endogenous TP53 genomic status with clonogenicity and different modes of cell death after X irradiation.

Juxian Lu-Hesselmann1, Michael Abend, Dirk van Beuningen.   

Abstract

Although extensive data indicate that the tumor suppressor TP53 modifies the radiation responses of human and rodent cells, the exact relationship between TP53 and radiation responsiveness remains controversial. To elucidate the relevance of endogenous TP53 genomic status to radiosensitivity in a cell-type-independent manner, different cells of 10 human tumor cell lines with different tissues of origin were examined for TP53 status. The TP53 status was compared with radiation-related cell survival parameters (D(q), D(0), SF2) and with the mode of cell death. Different modes of cell death were examined by measuring radiation-induced micronucleation, apoptosis and abnormal cells. Alterations of the TP53 gene were detected in eight cell lines. No splicing mutation was found. Five cell lines showed codon 68 polymorphism. Codon 72 alterations were found in four cell lines. "Hot spot" alterations were detected in only two of 10 cell lines. Although the cells differed widely in survival parameters (D(q), D(0), SF2) and modes of cell death (micronucleation/apoptosis/abnormal cells) after irradiation, significant cell-type-independent correlations were obtained between the multiple cell death parameter micronucleation/apoptosis/abnormal cells and SF2 (P < 0.001) and D(q) (P = 0.003). Moreover, cells with a wild-type TP53 gene were more resistant to X rays than cells with a mutated TP53 gene or cells that were TP53-deficient. The alterations within exons 5-10 of the TP53 correlated with a enhanced radiosensitivity. For the first time, we demonstrated a correlation between endogenous genetic alterations within exons 5-10 of TP53 and radiation-related cell survival and cell death. This indicates a new molecular relevance of TP53 status to intrinsic cellular radiosensitivity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14680398     DOI: 10.1667/rr3092

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  3 in total

1.  Reducing intratumour acute hypoxia through bevacizumab treatment, referring to the response of quiescent tumour cells and metastatic potential.

Authors:  S Masunaga; Y Liu; H Tanaka; Y Sakurai; M Suzuki; N Kondo; A Maruhashi; K Ono
Journal:  Br J Radiol       Date:  2011-05-17       Impact factor: 3.039

2.  Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.

Authors:  Courtney A Lovejoy; Wendi Li; Steven Reisenweber; Supawat Thongthip; Joanne Bruno; Titia de Lange; Saurav De; John H J Petrini; Patricia A Sung; Maria Jasin; Joseph Rosenbluh; Yaara Zwang; Barbara A Weir; Charlie Hatton; Elena Ivanova; Laura Macconaill; Megan Hanna; William C Hahn; Neal F Lue; Roger R Reddel; Yuchen Jiao; Kenneth Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Alan K Meeker
Journal:  PLoS Genet       Date:  2012-07-19       Impact factor: 5.917

3.  Regulation of cell survival and death signals induced by oxidative stress.

Authors:  Mikinori Kuwabara; Taketoshi Asanuma; Koichi Niwa; Osamu Inanami
Journal:  J Clin Biochem Nutr       Date:  2008-09       Impact factor: 3.114

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.